Popular Articles

Applied NeuroSolutions Announces Promising Results For A Blood-Based Test For Alzheimer's Disease
Applied NeuroSolutions, Inc. (OTC BB:APSN), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer"s disease ("AD"), announced it has achieved promising results in its development of a blood-based test related to the diagnosis of patients with Alzheimer"s disease (AD). The results of two studies, which provided data from blinded serum samples, showed the ability of this tau-based test to differentiate between patients with AD and normal controls with a sensitivity greater than 80% and a specificity greater than 70%.
generic viagra online
Donors To Reevaluate Support For Myanmar's Fight Against HIV/AIDS
The AP/KTVZ.com examines how after years of strained relationships between the "military-run nation" of Myanmar and international donors that led to a large reduction in HIV/AIDS funding, donors are considering reinvesting in the country"s HIV/AIDS programs. According to AP/KTVZ.com, "Myanmar receives only about $3 per capita in aid, compared with $23 for Vietnam and $50 for Laos."
News of the day
Demand For User-friendly Healthcare IT Professional Services Increasing Across Europe, States Frost & Sullivan
The demand for more user-friendly healthcare IT professional services has been increasing across Europe. Companies that have delivered the right blend of 360 degree consulting, easier and shorter training sessions and exceptional operational services along with round-the-clock support and maintenance services have been displaying market leadership in terms of revenues and number of installed bases.
Public Health

New Code Of Ethics For More Transparent Medical Technology Industry

RAJ Devices, the regulatory affairs journal published by Informa and covering the medical technology industry, has published a comprehensive feature on how companies in the US can comply with a much stricter code of ethics that medical technology industry association AdvaMed will launch on 1 July. AdvaMed, which represents medical technology companies that produce 90% of devices and diagnostics sold in the US and 50% of those sold worldwide, is also encouraging companies that are not members to adopt its new code. "The revised code contains completely new guidance in a number of areas," says Andrew Van Haute,associate general counsel at AdvaMed. The new rules cover, among other things, the payment of royalties to healthcare professionals who help develop medical technology; the provision of demonstration and evaluation products; and the complete prohibition on gifts, entertainment and recreation. In addition, the code provides strong encouragement and incentives to companies who certify that they will comply. Medical technology companies and the healthcare profession are entering a new era in terms of how they deal with each other. Federal and state legislatures in the US are considering or have already passed disclosure laws affecting companies and healthcare professionals. Efforts to improve transparency outside the US are also under way by industry bodies. Medical professionals often work in tandem with companies to invent and improve upon medical devices, Mr Van Haute explains. Both parties also collaborate to design effective clinical trials of devices and once a product is in the field, companies work closely with healthcare professionals to ensure the product is used properly. While these interactions are clearly necessary and vital, they occasionally present the potential for conflicts of interest in that healthcare professionals might base clinical decisions on their relationship with a company rather than on the best interests of their patients. As such, the relationships between physicians and industry have come under the scrutiny of lawmakers, prosecutors and the public. For many years, AdvaMed has made available a code of ethics to help industry ensure that all decisions made by healthcare professionals were based on the best interests of their individual patients and not on their relationship with a medical technology company. However, with the revised code, AdvaMed is helping to extend patient protection with greater transparency and clear demarcations for industry relationships. "The new code spells out the rules in very certain terms," says Neena Brizmohun, Deputy Editor of RAJ Devices. "Training, educational conferences, entertainment, gifts, consulting arrangements, meals, royalty payments, grants and donations, and overall code compliance are all covered in detail." RAJ Devices


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):